Anonymous - Comment

Document ID: FDA-2010-N-0465-0002
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: September 22 2010, at 12:00 AM Eastern Daylight Time
Date Posted: October 12 2010, at 12:00 AM Eastern Standard Time
Comment Start Date: September 22 2010, at 12:00 AM Eastern Standard Time
Comment Due Date: November 22 2010, at 11:59 PM Eastern Standard Time
Tracking Number: 80b556db
View Document:  View as format xml

View Comment

fda 2010 N 0465 - attn elizabeth berbakos present ads present no fair balance at all. there is 2 pages of hype on benefits of the drug. a few words about the contraindications. this survey is so unnecessary and such a waste of tax dollars. we all know this. we all know already how consumers take this information. i really dont think you need to do this survey. you can see from teh way the ads are presented what the big money big pharma con men are up to. you really dont need to waste tax dollars on this survey. ythis agency is such a free overspender on nothing good for america and it wastes american tax dollars right and left.

Related Comments

    View All
Total: 6
Anonymous - Comment
Public Submission    Posted: 10/12/2010     ID: FDA-2010-N-0465-0002

Nov 22,2010 11:59 PM ET
Bausch+Lomb - Comment
Public Submission    Posted: 12/21/2010     ID: FDA-2010-N-0465-0004

Nov 22,2010 11:59 PM ET
McKesson Corporation - Comment
Public Submission    Posted: 12/21/2010     ID: FDA-2010-N-0465-0005

Nov 22,2010 11:59 PM ET
Community Catalyst - Comment
Public Submission    Posted: 12/21/2010     ID: FDA-2010-N-0465-0006

Nov 22,2010 11:59 PM ET
Pharmaceutical Research and Manufacturers of America (PhRMA) - Comment
Public Submission    Posted: 12/21/2010     ID: FDA-2010-N-0465-0007

Nov 22,2010 11:59 PM ET